Search
for
Sort by
Research 691–720 of 1000+
- Total prostate volume as risk factor for semen pathologies in ageing male
- Faculty Opinions recommendation of Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial.
- Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?
- Genetic analysis of the role of androgen metabolism in the pathogenesis of prostate cancer
- Influencia del tratamiento con alfa bloqueantes e inhibidores de la 5 alfa reductasa en los hallazgos morfológicos e inmunohistoquímicos de la hiperplasia benigna de próstata
- Comparación del efecto terapéutico entre el extracto etanólico del fruto de Physalis peruviana, Finasteride y Terazosine en la hiperplasia prostática benigna inducida en ratas
- One year cross-sectional study of association between androgenetic alopecia and benign prostatic hyperplasia in a tertiary care hospital
- Comorbidities in patients with androgenetic alopecia: cardiovascular risk factors and benign prostatic hyperplasia
- 409 ANDROGEN RECEPTOR GENE POLYMORPHISM (SNP RS6152) – ITS RELATIONSHIP TO ANDROGEN-SENSITIVE GENES EXPRESSION IN BENIGN PROSTATIC HYPERPLASIA, CARCINOMA OF THE PROSTATE AND ANDROGENETIC ALOPECIA
- 1407 ANDROGENETIC ALOPECIA, PROSTATE VOLUME AND URINARY SYMPTOMS. IS THERE A RELATIONSHIP? A CASE-CONTROL STUDY
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- Patients with a large prostate show a higher prevalence of androgenetic alopecia
- The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention
- 5-Alpha Reductase Inhibitors in Prostate Cancer: From Clinical Trials to Clinical Practice
- Alopecia androgenética masculina de inicio precoz asociada a cáncer de próstata
- Hair loss at 20 associated with prostate cancer risk later in life
- A Review on the Clinical Utility of PSA in Cancer Prostate
- Design, Synthesis, and Preclinical Evaluation of Prostate-Specific Membrane Antigen Targeted <sup>99m</sup>Tc-Radioimaging Agents
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- 5α‐Reductase Isozymes and Androgen Actions in the Prostate
- Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial
- Selenium and vitamin E supplements for prostate cancer: evidence or embellishment?
- Prostate cancer prevention
- Androgen Receptors and Androgen-Dependent Initiation of Protein Synthesis in the Prostate
- Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells
- 5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review
- A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer
- Androgen Receptor Gene Polymorphism and Prostate Zonal Volumes in Australian and Chinese Men
- Prevention and treatment of experimental prostate cancer in lobund-wistar rats. I. Effects of estradiol, dihydrotestosterone, and castration
- Baldness, benign prostate hyperplasia, prostate cancer and androgen levels